Vimarsana
Biggest News Aggregation in the World

Page 4 - Cancer Sci News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cancer Sci. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cancer Sci Today - Breaking & Trending Today

Genmab to Submit Biologics License Application to U.S. Food - Vimarsana News

Genmab to Submit Biologics License Application to U.S. Food

Company Announcement COPENHAGEN, Denmark; June 30, 2022 – Genmab A/S (Nasdaq: GMAB) today announced its intent to submit a biologics license application...

Genmab Announces Late-Breaking Phase 2 Trial Results of Investigational Epcoritamab (DuoBody®-CD3xCD - Vimarsana News

Genmab Announces Late-Breaking Phase 2 Trial Results of Investigational Epcoritamab (DuoBody®-CD3xCD

Epcoritamab demonstrated clinically meaningful efficacy in challenging to treat, highly refractory LBCL patients, including patients previously treated with chimeric antigen receptor (CAR) T-cell therapyTotal patient population achieved overall response rate (ORR) of 63 percent and complete response (CR) of 39 perce...

Genmab Announces Late-Breaking Phase 2 Trial Results of Investigational Epcoritamab (DuoBody-CD3xCD20) in Relapsed/Refractory Large B-cell Lymphoma (LBCL) Patients Presented at European Hematology Association (EHA) Presidential Symposium - Vimarsana News

Genmab Announces Late-Breaking Phase 2 Trial Results of Investigational Epcoritamab (DuoBody-CD3xCD20) in Relapsed/Refractory Large B-cell Lymphoma (LBCL) Patients Presented at European Hematology Association (EHA) Presidential Symposium

Epcoritamab demonstrated clinically meaningful efficacy in challenging to treat, highly refractory LBCL patients, including patients previously treated with chimeric antigen receptor (CAR) T-cell

Frontiers | GPX7 Is Targeted by miR-29b and GPX7 Knockdown Enhances Ferroptosis Induced by Erastin in Glioma - Vimarsana News

Frontiers | GPX7 Is Targeted by miR-29b and GPX7 Knockdown Enhances Ferroptosis Induced by Erastin in Glioma

Background Glioma is a lethal primary tumor of central nervous system. Ferroptosis is a newly identified form of necrotic cell death. Triggering ferroptosis has shown potential to eliminate aggressive tumors. GPX7, a member of glutathione peroxidase family (GPXs), has been described to participate in oxidative stress and tumorigenesis. However, the biological functions of GPX7 in glioma are still unknown. Methods Bioinformatics method was used to assess the prognostic role of GPX7 in glioma. CCK8, wound healing, transwell and cell apoptosis assays were performed to explore the functions of GPX...

Don't Fall for the Myths About Soy - Vimarsana News

Don't Fall for the Myths About Soy

Contrary to the negative soy information floating about in today’s technological world, the scientific consensus shows soy is ...